1 |
De Vries C J, Escobedo A, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991
DOI
|
2 |
Folkman J (1991) What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer lnst. 82:4-6
|
3 |
Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1, J. Biol. Chem. 277:27872-27879
DOI
ScienceOn
|
4 |
Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch A E (1994) Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. USA. 91:4190-4194
|
5 |
Montesano R, Vassalli JD, Baird A, Guillemin Rand Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA. 83:7297-7301
|
6 |
Thomas KA (1987) Fibroblast growth factors. FASEB. 1:434-440
DOI
|
7 |
Ncosia RF, Tchao R, Leighton J (1983) Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res. 43:2159-2166
|
8 |
Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442-447
DOI
|
9 |
Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, Galis ZS (2004) Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation, 109:520-525
DOI
ScienceOn
|
10 |
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Frrarara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen, Science 246: 1306-1309
DOI
|
11 |
Vlodavsky I, Folkman J, Sullivan R, Fridman R, IshaiMicbaelli R, Sasse J, Klagsbrun M (1987) Endothelial cellderived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA. 84:2292-2296
|
12 |
Veikkola, T. Alitalo, K. (1999) VEGFs, receptors and angiogenesis, Semin. Cancer Biol. 9:211-220
|
13 |
Wei XL, Ru XB (1997) Effects of low-molecular-weight Rehmannia glutinosa polysaccharides on p53 gene expression. Zhongguo Yaoli Xuebao 18:471-474
|
14 |
Cho SI (2003) Anti-oxidative effects of Rehmannia Radix Preparata on toxic agent induced kidney cell injury. Kor. J. Herbology 18:119-126
|
15 |
Kim HM, An CS, Jung KY, Cboo YK, Park JK, Nam SY (1999) Rehmannia glutinosa inhibits tumour necrosis factoralpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res. 40:171-176
DOI
ScienceOn
|
16 |
Risau W (1990) Angiogenic growth factors. Prog. Growth Factor Res. 2:71-79
DOI
ScienceOn
|
17 |
Kim SS, Son YO, Chun JC, Kim SE, Chung GH, Hwang KJ, Lee JC (2005) Antioxidant property of an active component purified from the leaves of paraquat-tolerant Rehmannia glutinosa. Redox Rep. 10(6):311-8
DOI
ScienceOn
|
18 |
Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator ofvasculogenesis and angiogenesis. Cell 72: 835-846
DOI
ScienceOn
|
19 |
Tomoda M, Miyamoto H, Shimizu N, Gonda R, Obara N (1994) Characterization oftwo polysaccharides having activity on the reticuloendothelial system from the root of Rehmannia glutinosa. Chem Pharm Bull (Tokyo) 42:625-62
DOI
ScienceOn
|
20 |
Tian YY, An LJ, Jiang L, Duan YL, Chen J, Jiang B (2006) Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures. Life Sci. 23(80):193-9
|
21 |
Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94:2036-2044
DOI
ScienceOn
|
22 |
Boehm-Viswanathan T (2000) Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr. Opin. Oncol. 12:89-94
DOI
ScienceOn
|